BioNTech SE (BNTX)
NASDAQ: BNTX · Real-Time Price · USD
103.15
+0.45 (0.44%)
At close: Nov 28, 2025, 4:00 PM EST
102.90
-0.25 (-0.24%)
After-hours: Nov 28, 2025, 4:15 PM EST
BioNTech SE Stock Forecast
Stock Price Forecast
The 11 analysts that cover BioNTech SE stock have a consensus rating of "Buy" and an average price target of $137.4, which forecasts a 33.20% increase in the stock price over the next year. The lowest target is $110 and the highest is $171.44.
Price Target: $137.4 (+33.20%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for BioNTech SE stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jun '25 | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 10 | 10 | 10 | 8 | 7 | 5 |
| Buy | 4 | 4 | 4 | 4 | 4 | 3 |
| Hold | 4 | 4 | 4 | 3 | 3 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 18 | 18 | 18 | 15 | 14 | 11 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $136 → $140 | Strong Buy | Maintains | $136 → $140 | +35.72% | Nov 10, 2025 |
| UBS | UBS | Hold Maintains $115 → $117 | Hold | Maintains | $115 → $117 | +13.43% | Nov 6, 2025 |
| JP Morgan | JP Morgan | Hold Maintains $121 → $120 | Hold | Maintains | $121 → $120 | +16.34% | Oct 23, 2025 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $133 → $131 | Buy | Maintains | $133 → $131 | +27.00% | Oct 10, 2025 |
| JP Morgan | JP Morgan | Hold Maintains $116 → $121 | Hold | Maintains | $116 → $121 | +17.30% | Sep 22, 2025 |
Financial Forecast
Revenue This Year
2.27B
from 2.75B
Decreased by -17.67%
Revenue Next Year
2.48B
from 2.27B
Increased by 9.49%
EPS This Year
-4.81
from -2.77
EPS Next Year
-3.75
from -4.81
Financial currency is EUR. Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 3.5B | 3.4B | ||||
| Avg | 2.3B | 2.5B | ||||
| Low | 1.6B | 1.6B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 26.9% | 49.8% | ||||
| Avg | -17.7% | 9.5% | ||||
| Low | -42.6% | -31.5% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | -1.16 | 0.11 | ||||
| Avg | -4.81 | -3.75 | ||||
| Low | -7.53 | -8.00 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | - | - | ||||
| Avg | - | - | ||||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.